Tuberculin skin testing underestimates a high prevalence of latent tuberculosis infection in hemodialysis patients.
about
Whole-blood flow-cytometric analysis of antigen-specific CD4 T-cell cytokine profiles distinguishes active tuberculosis from non-active statesSurprisingly high specificity of the PPD skin test for M. tuberculosis infection from recent exposure in The GambiaCytometric detection of antigen-specific IFN-gamma/IL-2 secreting cells in the diagnosis of tuberculosis.Risk factors for tuberculosis in dialysis patients: a prospective multi-center clinical trialDendritic Cell Dysfunction in Patients with End-stage Renal DiseaseHigh prevalence of latent tuberculosis infection in dialysis patients using the interferon-gamma release assay and tuberculin skin test.Value of the tuberculin skin testing and of an interferon-gamma release assay in haemodialysis patients after exposure to M. tuberculosis.Predictors and prevalence of latent tuberculosis infection in patients receiving long-term hemodialysis and peritoneal dialysis.Heparin-binding haemagglutinin, a new tool for the detection of latent Mycobacterium tuberculosis infection in hemodialysis patientsAntigen-specific CD4 T cells are induced after intravesical BCG-instillation therapy in patients with bladder cancer and show similar cytokine profiles as in active tuberculosisComparison of interferon gamma release assay & tuberculin skin tests for diagnosis of latent tuberculosis in patients on maintenance haemodialysis.Interferon-gamma release assays for diagnosing mycobacterium tuberculosis infection in renal dialysis patients.Use of the QuantiFERON-TB Gold interferon-gamma release assay for screening transplant candidates: a single-center retrospective study.Tuberculosis in transplantation: diagnosis, prevention, and treatment.TB or not TB: the role of immunodiagnosis.Bacillus Calmette-Guérin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles.Smear grading and the Mantoux skin test can be used to predict sputum smear conversion in patients suffering from tuberculosis.Performance of QuantiFERON(®)-TB Gold In-Tube assay in children receiving disease modifying anti-rheumatic drugs.Effectiveness of Herpes Zoster Vaccine in Patients 60 Years and Older With End-stage Renal Disease.Diagnostic potential of interferon-gamma release assay to detect latent tuberculosis infection in kidney transplant recipients.Tuberculosis of the breast in a patient undergoing hemodialysis.The prevalence and the characteristics of tuberculosis patients undergoing chronic dialysis treatment: experience of a dialysis center in southeast Turkey.Superior Sensitivity of Ex Vivo IFN-γ Release Assays as Compared to Skin Testing in Immunocompromised Patients.Feasibility of the interferon-gamma enzyme-linked immunospot assay in chronic renal failure patients and immunocompetent subjects: a head-to-head comparison.Comparative analysis of assays for detection of cell-mediated immunity toward cytomegalovirus and M. tuberculosis in samples from deceased organ donors.Prevalence of latent tuberculosis and treatment adherence among patients with chronic kidney disease in Campo Grande, State of Mato Grosso do Sul.The performance of quantiferon-TB gold in-tube (QFT-IT) test compared to tuberculin skin test (TST) in detecting latent tuberculosis infection (LTBI) in the presence of HIV coinfection in a high TB-burden area with BCG-vaccinated population.Mycobacterium tuberculosis infection incidence in hospitalized renal transplant patients in the United States, 1998-2000.Interferon Gamma Release Assays to Diagnose Latent Tuberculosis Infection in Pediatric Dialysis Patients.Incidence of tuberculosis disease and latent tuberculosis infection in patients with end stage renal disease in an endemic region.Transmission of Mycobacterium tuberculosis undetected by tuberculin skin testing.Diagnosis of Mycobacterium tuberculosis infection using ESAT-6 and intracellular cytokine cytometry.Intention to Test Is Intention to Treat
P2860
Q28741912-FB425584-AD31-4454-9540-5AF086CD2E75Q30828531-360706A5-86A4-45B6-9670-038773C0E7F8Q33473026-07DC4370-2B1E-4DD9-BD64-A4AC3820E70CQ33515430-00648FFB-6A78-4D24-813E-7F0816798569Q33835103-69899D9E-9D00-411E-93F1-20DDB772BAACQ34075496-C723FA7D-B755-4F08-944E-5A55B3551678Q34385468-A83913EF-FE04-49AC-AC4E-2467AB98CF20Q34390905-B1DC26A7-502D-400B-B666-C4FCCA38A140Q34936752-E5B0CE38-9463-4F18-B73B-D1AF48C884DBQ34988147-FC33E4D8-6AAC-46BF-A495-A0F90DDF8669Q35877799-932BE49C-DAEF-42B6-9089-4ECE026AC113Q36843374-0AEFB3FF-51A5-40C0-9D83-AE7ED8669E08Q37924932-3B3DFF92-2EB8-4361-8537-BADC53FF677EQ38042874-E27D1D2D-6505-4658-973B-446424F44E68Q39528913-B092934A-7EC0-4E12-9922-64305F20689DQ39707019-8109242B-EE07-43E4-B25C-EDB0B7B8F1EFQ40079996-E227DF02-28D4-4BBF-B091-190A805F8F87Q40159900-BEFD832A-E25B-4B1A-BFD5-657448930201Q40208145-D058D1C6-3733-405A-B3BD-96A1D47168D0Q40341751-FBA1327F-9ADD-42FF-9ADD-5AFFE8D0A16DQ40362195-9EB4C598-487C-4F31-ABD8-2704DE81D6C4Q40416338-94C0E22F-E969-4C80-8664-60850ED74B87Q41201019-632267CF-E106-4C2F-AE9D-22445CBF3DFEQ41667766-1952D87D-19D2-45A4-B1BD-7F87C341B05EQ42205166-3EFD4C52-9A72-46C8-B0A4-2F4F43F4FBAFQ44186551-4DD55769-C01A-47E2-B2F2-4689FFC60445Q44374379-63D8F9C1-DA86-44E4-A4CE-AE26DF7705DAQ44401765-7C9A6E38-A238-4509-88F9-8DC2442BADA6Q44784238-CAB09C1E-C60E-4C98-B320-5E1EF7EE5E2FQ44836771-A7F16E96-37C5-4DC8-87AB-772C0A4C96C7Q46925937-4513F10E-7485-4436-A5BE-3C183903B2B2Q47723579-DE10E82A-F2F2-4208-905B-34480BC9E9A7Q58321524-0027E287-E596-4726-AB58-0B36A553B728
P2860
Tuberculin skin testing underestimates a high prevalence of latent tuberculosis infection in hemodialysis patients.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Tuberculin skin testing undere ...... tion in hemodialysis patients.
@en
Tuberculin skin testing undere ...... tion in hemodialysis patients.
@nl
type
label
Tuberculin skin testing undere ...... tion in hemodialysis patients.
@en
Tuberculin skin testing undere ...... tion in hemodialysis patients.
@nl
prefLabel
Tuberculin skin testing undere ...... tion in hemodialysis patients.
@en
Tuberculin skin testing undere ...... tion in hemodialysis patients.
@nl
P2093
P50
P1433
P1476
Tuberculin skin testing undere ...... tion in hemodialysis patients.
@en
P2093
Gerhard W Sybrecht
Gunnar Heine
Hans Köhler
Peter Clauer
Thomas Moll
Ulrich Mack
P304
P356
10.1111/J.1523-1755.2004.00586.X
P407
P577
2004-05-01T00:00:00Z
P5875
P6179
1000860918